Form 8-K - Current report:
SEC Accession No. 0001493152-26-027201
Filing Date
2026-06-04
Accepted
2026-06-04 08:00:40
Documents
17
Period of Report
2026-06-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 63930
2 EX-3.1 ex3-1.htm EX-3.1 103789
3 EX-10.1 ex10-1.htm EX-10.1 126681
4 EX-10.2 ex10-2.htm EX-10.2 54913
5 EX-10.3 ex10-3.htm EX-10.3 51199
6 EX-99.1 ex99-1.htm EX-99.1 26403
7 GRAPHIC ex99-1_001.jpg GRAPHIC 14223
  Complete submission text file 0001493152-26-027201.txt   702122

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE imnn-20260601.xsd EX-101.SCH 3008
9 XBRL LABEL FILE imnn-20260601_lab.xml EX-101.LAB 34239
10 XBRL PRESENTATION FILE imnn-20260601_pre.xml EX-101.PRE 22354
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3337
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15911 | Film No.: 261063246
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)